Roth MKM Reiterates Buy on Phibro Animal Health, Maintains $21 Price Target
Portfolio Pulse from richadhand@benzinga.com
Roth MKM analyst Brian Wright has reiterated a 'Buy' rating on Phibro Animal Health (NASDAQ:PAHC), maintaining a price target of $21.
August 29, 2023 | 12:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Phibro Animal Health's stock rating has been reiterated as 'Buy' by Roth MKM with a maintained price target of $21.
The reiteration of a 'Buy' rating by a reputable analyst like Brian Wright from Roth MKM is a positive signal for investors. The maintained price target of $21 indicates the analyst's confidence in the company's potential growth. This could lead to increased investor confidence and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100